Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
53 /100
HIGH RISK
Score updated Aug 28, 2026

JBIO — Jade Biosciences, Inc. Dilution Risk Tracker

Track JBIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track JBIO — Get alerts when the score changes →

As of August 28, 2026, Jade Biosciences, Inc. (JBIO) has a DilutionWatch DilutionScore of 53/100, rated HIGH dilution risk. Jade Biosciences, Inc. has a market capitalization of $1.04B, 63.60M shares outstanding, 122 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
72
💰 Cash Runway
0
📊 Float Risk
55
⚠️ Warrant Exposure
40
🔄 Convertible Debt
35

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
🔁 Convertible Conversion model 15%
• Convertible debt present: 9.1% potential dilution
🔔 Track JBIO — Get forecast alerts →

Market Data

Market Cap$1.04B
Shares Outstanding63.60M
Float32.74M
Cash$461.20M
Debt$849.0K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 23.5% shares (2026Q1 vs prior)
122 institutional holders · 58.64M shares
#1 FMR LLC 7.09M shares
#2 JANUS HENDERSON GROUP PLC 6.21M shares
#3 Fairmount Funds Management LLC 4.55M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest8.69M
Days to Cover11.5
% of Float26.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2025-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual JBIO Dilution Snapshot

Jade Biosciences, Inc. (JBIO) has a DilutionScore of 53/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track JBIO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking JBIO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for JBIO
JBIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.